Biliary Tract Cancer Recruiting Phase 2 Trials for Durvalumab (DB11714)

Also known as: Biliary tract cancer / Cancers, Biliary Tract / Malignant neoplasm of biliary tract, unspecified / Malignant tumor of biliary tract / Malignant neoplasm of biliary tract, part unspecified

IndicationStatusPhase
DBCOND0030617 (Biliary Tract Cancer)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03482102Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract CancerTreatment